Synthesis of 2-Aryl-(Z)-4-(halomethylidene)-4H-3,1-benzoxazines by sodium hydride mediated cyclization of N-[2-(2,2-dihaloethenyl) phenyl] arenecarboxamides

Article abstract of DOI:10.3987/COM-14-13127

A simple two-step procedure for the preparation of 2-aryl-(Z)-4-(halomethylidene)-4H-3,1-benzoxazines from readily available 2-(2,2-dihaloethenyl)benzenamines is developed. Thus, these amines were N-aroylated with the respective aroyl chloride to give N-[

Full text of DOI:10.3987/COM-14-13127

HETEROCYCLES, Vol. 89, No. 12, 2014
2729
HETEROCYCLES, Vol. 89, No. 12, 2014, pp. 2729 - 2738. © 2014 The Japan Institute of Heterocyclic Chemistry
Received, 13th November, 2014, Accepted, 3rd December, 2014, Published online, 10th December, 2014
DOI: 10.3987/COM-14-13127
SYNTHESIS OF 2-ARYL-(Z)-4-(HALOMETHYLIDENE)-4H-3,1-
BENZOXAZINES BY SODIUM HYDRIDE MEDIATED CYCLIZATION
OF N-[2-(2,2-DIHALOETHENYL)PHENYL]ARENECARBOXAMIDES
Kazuhiro Kobayashi,* Ippei Nozawa, and Daiki Kado
Division of Applied Chemistry, Department of Chemistry and Biotechnology,
Graduate School of Engineering, Tottori University, 4-101 Koyama-minami,
Tottori 680-8552, Japan; E-mail: kkoba@chem.tottori-u.ac.jp
Abstract – A simple two-step procedure for the preparation of 2-aryl-(Z)-4-
(halomethylidene)-4H-3,1-benzoxazines from readily available 2-(2,2-
dihaloethenyl)benzenamines is developed. Thus, these amines were N-aroylated
with
the
respective
aroyl
chloride
to
give
N-[2-(2,2-
dihaloethenyl)phenyl]arenecarboxamides, which in turn were treated with sodium
hydride to afford the desired products.
INTRODUCTION
As 4-alkylidene-4H-3,1-benzoxazine derivatives are of synthetically importance, a number of methods
for the preparation of this class of molecules have recently been reported.1,2 On the other hand, our
previous study has shown that 2-(2,2-dihaloethenyl)phenyl isothiocyanates were easily prepared from the
respective 2-(2,2-dihaloethenyl)benzenamines and that the corresponding thiourea derivatives, derived
from these isothiocyanates and secondary amines, underwent ring closure on treatment with sodium
hydride to result in the stereoselective formation of N,N-disubstituted (Z)-4-(halomethylidene)-4H-3,1-
benzothiazin-2-amines.3 So, we became interested in the possibility of extending this type of ring closure
for the construction of the (Z)-4-(halomethylidene)-4H-3,1-benzoxazine structure. In this paper, we wish
to report a simple approach to (Z)-4-(halomethylidene)-2-(het)aryl-4H-3,1-benzoxazines (3) from
2-(2,2-dihaloethenyl)benzenamines (1), which involves the N-(het)aroylation of 1 with (het)aroyl
chlorides and subsequent treatment of the resulting amides (2) with sodium hydride under mild conditions.
We also demonstrate !-hydroxyalkylation on the carbon adjacent to the chloro atom of a
4-(chloromethylidene) derivative.

2730
HETEROCYCLES, Vol. 89, No. 12, 2014
RESULTS AND DISCUSSION
The synthesis of 4H-3,1-benzoxazine derivatives (3) was conducted according to the sequence illustrated
in Scheme 1. N-[2-(2,2-Dihaloethenyl)phenyl](het)arenecarboxamides (2), excluding 2i, were prepared
by the reaction of 2-(2,2-dihaloethenyl)benzenamines (1), readily obtainable from commercially available
2-nitrobenzaldehydes according to the appropriate reported procedures,4-7 with (het)aroyl chlorides in
saturated aqueous sodium hydrogencarbonate at room temperature. The pyridine-3-carboxamide
derivative (2i) could be obtained by N-(pyridine-3-carbonyl)ation of 1c with pyridine-3-carbonyl chloride
hydrochloride in THF in the presence of two equivalents of triethylamine at room temperature (Scheme 2).
In each case, the yield of the product was good as compiled in Table 1.
X
X
X
X
X
R
R
R
ArCOCl
NaH, DMF
O
sat. aq. NaHCO3
0 ˚C (X = Br) or rt (X = Cl)
NHCOAr
NH2
N
Ar
2
3
1
Scheme 1
Br
Br
O
Br
Br
COCl
Cl
Cl
2 Et3N, THF, rt
+
+
N
N
H
N
HCl–
NH2
1c
2i
Scheme 2
Table 1. Preparation of (Z)-4-(halomethylidene)-4H-3,1-benzoxazines (3)
Entry
1
Ar
Ph
2
Yield/%a
3
Yield/%a
76
1
2
1a (R = H, X = Br)
2a
2b
2c
2d
2e
2f
76
3a
3b
3c
3d
3e
3f
1a
3-MeC6H4
4-ClC6H4
3-MeOC6H4
Ph
82
69
3
1a
79
77
4
1a
82
76
5
1b (R = H, X = Cl)
79
86
6
1b
thiophen-2-yl
Ph
77
69
7
1c (R = Cl, X = Br)
2g
2h
2i
72
3g
3h
3i
73
8
1c
3-ClC6H4
pyridin-3-yl
Ph
66
81
9
1c
67
71
10
11
1d (R = OMe, X = Br)
2j
82
3j
71
1d
4-ClC6H4
2k
83
3k
73
a Yields of isolated products.

HETEROCYCLES, Vol. 89, No. 12, 2014
2731
These amides (2), thus obtained, were subsequently transformed into the corresponding desired
(Z)-4-(halomethylidene)-4H-3,1-benzoxazine derivatives (3) in generally good yields on treatment with
sodium hydride in DMF. These results are also compiled in Table 1. While the ring closure sequence of
the 2,2-dibromoethenyl substrates proceeded very smoothly at 0 ˚C, that of the 2,2-dichloroethenyl
substrate was reluctant at 0 ˚C and room temperature was required for an adequate progress and
satisfactory production of the desired products. The ring closure sequence proceeded with complete
stereoselectivity to give 3. Entry 9 shows that cyclization of pyridine-3-carboxamide precursor 2i under
the same conditions gave also the corresponding desired product 3i in a yield comparable to the others.
Each of these products could be isolated in a pure form by recrystallization after usual aqueous workup.
The stereochemistry of the 4-halomethylidene unit of each product was assigned to be Z on the basis of
NOESY analyses of the products. For example, an interaction between the vinyl proton (" 5.97) and
5-proton (" 7.35) of 3g was observed. The exclusive formation of Z-isomer is due to the avoidance of the
steric repulsion between the halogen atom and 5-H.
It is notable that all attempts to prepare 2-alkyl-4-(halomethylidene)-4H-3,1-benzoxazine derivatives
from N-[2-(2,2-dihaloethenyl)phenyl]alkanamides under the same conditions as described above resulted
in the formation of complex reaction mixtures. The corresponding desired products are thought to be
unstable under reaction and/or work-up conditions.
The formation of 3 from 2 probably proceeds in an analogous manner to that indicated previously for the
formation of N,N-disubstituted (Z)-4-(halomethylidene)-4H-3,1-benzothiazin-2-amines from the
respective thiourea derivatives, derived from 2-(2,2-dihaloethenyl)phenyl isothiocyanates and secondary
amine.3 As illustrated in Scheme 3, deprotonation of the amide NH hydrogen of 2 with sodium hydride
gave the imidate anion intermediate 4. Then, attack of the oxy anion on the #-position of the dihalovinyl
function gives !,!-dihalo carbanion intermediate 5. Proton transfer gives the benzyl anion intermediate 6,
from which a halide anion is eliminated to give rise to 3. Thus, the slow production of 3 with X = Cl is
indicative of the fact that the corresponding intermediates 5 with X = Cl are more stable than that with X
= Br.
X
X
X
X
X
X
– X–
R
R
NaH
O
R
3
O
O–
2
N
Ar
N
Ar
N
Ar
6
5
4
Scheme 3

2732
HETEROCYCLES, Vol. 89, No. 12, 2014
In order to demonstrate the synthetic utility of these novel compounds (3), we next explored the reaction
of 3a and 3e with butyllithium. When 3a was successively treated with butyllithium and benzaldehyde in
THF at –78 ˚C, an inseparable mixture of the products including those arising from the lithiation at the
vinyl carbon and the bromine/lithium exchange was obtained after aqueous workup. In the case of 3e, the
lithiation at the vinyl carbon took place selectively, and the resulting lithium compound reacted with
carbonyl compounds, such as benzaldehydes and methyl 2-oxopropanoate, to afford the corresponding
desired products 7 in fair yields, as shown in Scheme 4.
R'
R
Cl
O
Cl
O
HO
1. n-BuLi, THF, –78 ˚C
2. RCOR', –78 ˚C
N
Ph
N
Ph
3e
7a R = Ph, R' = H 68%
7b R = Me, R' = CO2Me 62%
Scheme 4
In conclusion, the present study has led to the development of a convenient method for the preparation of
a new type of 4H-3,1-benzoxazines, (Z)-4-(halomethylidene)-2-(het)aryl-4H-3,1-benzoxazines. Simple
manipulations as well as the readily availability of the starting materials make it attractive. Investigations
of possibility of utilizing these 4H-3,1-benzoxazine derivatives for elaboration to the other heterocyclic
systems are presently under way in our laboratory.
EXPERIMENTAL
All melting points were obtained on a Laboratory Devices MEL-TEMP II melting apparatus and are
uncorrected. IR spectra were recorded as KBr discs, unless otherwise stated, with a Perkin–Elmer
Spectrum65 FTIR spectrophotometer. 1H NMR spectra were recorded using TMS as an internal reference
with a JEOL ECP500 FT NMR spectrometer operating at 500 MHz or Bruker Biospin AVANCE II 600
13
FT NMR spectrometer at 600 MHz. C NMR spectra were recorded using TMS as an internal reference
with a JEOL ECP500 FT NMR spectrometer operating at 125 MHz. High-resolution MS spectra were
measured by a Thermo Scientific Exactive spectrometer. Elemental analyses were performed with an
Elementar Vario EL II instrument. TLC was carried out on Merck Kieselgel 60 PF254. Column
chromatography was performed using WAKO GEL C-200E. All of the organic solvents used in this study
were dried over appropriate drying agents and distilled prior to use.

HETEROCYCLES, Vol. 89, No. 12, 2014
2733
Starting Materials. 2-(2,2-Dihaloethenyl)benzenamines 1a,4 1b,5 1c,6 and 1d7 were prepared according
to the appropriate reported procedures. n-BuLi was supplied by Asia Lithium Corporation. All other
chemicals used in this study were commercially available.
Typical Procedure for the Preparation of N-[2-(2,2-Dihaloethenyl)phenyl]benzamides (2),
Excluding 2i. N-[2-(2,2-Dibromoethenyl)phenyl]benzamide (2a).8 To a stirring mixture of 1a (0.22 g,
0.81 mmol) in saturated aqueous NaHCO3 (8 mL) at rt was added BzCl (0.13 g, 0.89 mmol) dropwise.
After 1 h, AcOEt (10 mL) was added and the layers were separated. The aqueous layer was extracted with
AcOEt (2 $ 5 mL) and the combined organic layers were washed with brine (10 mL), dried (Na2SO4), and
concentrated by evaporation. The residual solid was recrystallized from hexane/CH2Cl2 to give 2a (0.24 g,
76%); a white solid; mp 111–112 ˚C; IR 3235, 1647 cm–1; 1H NMR (500 MHz, CDCl3) " 7.22 (t, J = 7.4
Hz, 1H), 7.39 (d, J = 7.4 Hz, 1H), 7.44 (dd, J = 8.6, 7.4 Hz, 1H), 7.50 (s, 1H), 7.54 (t, J = 7.4 Hz, 2H),
7.60 (t, J = 7.4 Hz, 1H), 7.78 (br, 1H), 7.89 (d, J = 7.4 Hz, 2H), 8.16 (d, J = 8.6 Hz, 1H).
N-[2-(2,2-Dibromoethenyl)phenyl]-3-methylbenzamide (2b): a white solid; mp 103–104 ˚C
1
(hexane/CH2Cl2); IR 3241, 1647 cm–1; H NMR (500 MHz, CDCl3) " 2.47 (s, 3H), 7.22 (t, J = 7.4 Hz,
1H), 7.38–7.45 (m, 4H), 7.50 (s, 1H), 7.66 (d, J = 7.4 Hz, 1H), 7.71 (br s, 1H), 7.78 (br, 1H), 8.15 (d, J =
8.4 Hz, 1H). Anal. Calcd for C16H13Br2NO: C, 48.64; H, 3.32; N, 3.55. Found: C, 48.59; H, 3.41; N, 3.42.
4-Chloro-N-[2-(2,2-dibromoethenyl)phenyl]benzamide (2c): a white solid; mp 162–164 ˚C
(hexane/CH2Cl2); IR 3268, 1654 cm–1; 1H NMR (500 MHz, CDCl3) " 7.22 (t, J = 7.6 Hz, 1H), 7.37 (d, J =
7.6 Hz, 1H), 7.41 (t, J = 7.6 Hz, 1H), 7.48 (s, 1H), 7.49 (d, J = 8.4 Hz, 2H), 7.77 (br, 1H), 7.81 (d, J = 8.4
Hz, 2H), 8.06 (d, J = 7.6 Hz, 1H). Anal. Calcd for C15H10Br2ClNO: C, 43.36; H, 2.43; N, 3.37. Found: C,
43.26; H, 2.40; N, 3.19.
N-[2-(2,2-Dibromoethenyl)phenyl]-3-methoxybenzamide (2d): a white solid; mp 105–107 ˚C
1
(hexane/CH2Cl2); IR 3235, 1639 cm–1; H NMR (500 MHz, CDCl3) " 3.89 (s, 3H), 7.11 (tt, J = 7.4, 2.3
Hz, 1H), 7.21 (t, J = 7.4 Hz, 1H), 7.37 (d, J = 7.4 Hz, 1H), 7.39–7.44 (m, 4H), 7.49 (s, 1H), 7.81 (br, 1H),
8.14 (d, J = 8.6 Hz, 1H). Anal. Calcd for C16H13Br2NO2: C, 46.75; H, 3.19; N, 3.41. Found: C, 46.60;
3.19; N, 3.38.
N-[2-(2,2-Dichloroethenyl)phenyl]benzamide (2e): a white solid; mp 122–125 ˚C (hexane/CH2Cl2); IR
3250, 1647 cm–1; 1H NMR (500 MHz, CDCl3) " 6.90 (s, 1H), 7.23 (dd, J = 8.0, 7.4 Hz, 1H), 7.42 (dd, J =
8.0, 7.4 Hz, 1H), 7.45 (d, J = 8.0 Hz, 1H), 7.53 (dd, J = 7.4, 6.9 Hz, 2H), 7.59 (t, J = 7.4 Hz, 1H), 7.73 (br,
1H), 7.88 (d, J = 6.9 Hz, 2H), 8.09 (d, J = 8.0 Hz, 1H). Anal. Calcd for C15H11Cl2NO: C, 61.67; H, 3.79;
N, 4.79. Found: C, 61.51; 3.89; N, 4.72.
N-[2-(2,2-Dichloroethenyl)phenyl]thiophene-2-carboxamide (2f): a white solid; mp 130–132 ˚C
(hexane/CH2Cl2); IR 3245, 1630, 1600 cm–1; 1H NMR (500 MHz, CDCl3) " 6.91 (s, 1H), 7.16 (dd, J = 5.2,
4.0 Hz, 1H), 7.22 (ddd, J = 8.0, 7.4, 1.1 Hz, 1H), 7.40 (dd, J = 8.0, 7.4 Hz, 1H), 7.42 (d, J = 8.0 Hz, 1H),

2734
HETEROCYCLES, Vol. 89, No. 12, 2014
7.58 (dd, J = 5.2, 1.1 Hz, 1H), 7.60 (br, 1H), 7.62 (dd, J = 4.0, 1.1 Hz, 1H), 8.08 (d, J = 8.0 Hz, 1H). Anal.
Calcd for C13H9Cl2NOS: C, 52.36; H, 3.04; N, 4.70. Found: C, 52.39; 3.04; N, 4.49.
N-[4-Chloro-2-(2,2-dibromoethenyl)phenyl]benzamide (2g): a white solid; mp 151–153 ˚C
(hexane/CH2Cl2); IR 3234, 1648, 1603 cm–1; 1H NMR (500 MHz, CDCl3) " 7.36 (d, J = 2.3 Hz, 1H), 7.39
(dd, J = 8.6, 2.3 Hz, 1H), 7.43 (s, 1H), 7.54 (t, J = 7.4 Hz, 2H), 7.60 (tt, J = 7.4, 1.1 Hz, 1H), 7.74 (br,
1H), 7.87 (7.4, 1.1 Hz, 2H), 8.14 (d, J = 8.6 Hz, 1H). Anal. Calcd for C15H10Br2ClNO: C, 43.36; H, 2.43;
N, 3.37. Found: C, 43.36; 2.47; N, 3.39.
3-Chloro-N-[4-Chloro-2-(2,2-dibromoethenyl)phenyl]benzamide (2h): a white solid; mp 159–160 ˚C
(hexane/CH2Cl2); IR 3278, 1646 cm–1; 1H NMR (500 MHz, CDCl3) " 7.37 (d, J = 2.3 Hz, 1H), 7.40 (dd, J
= 8.6, 2.3 Hz, 1H), 7.43 (s, 1H), 7.47 (dd, J = 8.0, 7.4 Hz, 1H), 7.57 (dt, J = 8.0, 1.1 Hz, 1H), 7.69 (br,
1H), 7.71 (d, J = 8.0 Hz, 1H), 7.87 (t, J = 1.1 Hz, 1H), 8.08 (d, J = 8.6 Hz, 1H). Anal. Calcd for
C15H9Br2Cl2NO: C, 40.04; H, 2.02; N, 3.11. Found: C, 40.06; 2.04; N, 3.04.
N-[4-Chloro-2-(2,2-dibromoethenyl)phenyl]pyridine-3-carboxamide (2i). To a stirred mixture of 1c
(0.22 g, 0.71 mmol) and pyridine-3-carbonyl chloride hydrochloride (0.14 g, 0.78 mmol) in THF (3 mL)
at rt was added Et3N (0.18 g, 1.8 mmol), and stirring was continued overnight at the same temperature.
Saturated aqueous NaHCO3 (15 mL) was added, and the mixture was extracted with AcOEt (3 $ 10 mL).
The combined extracts were washed with water (3 $ 10 mL) and brine (5 mL), dried (Na2SO4), and
concentrated by evaporation. The residue was purified by column chromatography on silica gel to afford
1
2i (0.15 g, 67%); a pale-yellow viscous oil; Rf 0.25 (AcOEt/hexane 5:1); IR (neat) 3251, 1656 cm–1; H
NMR (500 MHz, CDCl3) " 7.38 (s, 1H), 7.41 (dd, J = 8.6, 2.3 Hz, 1H), 7.44 (s, 1H), 7.49 (dd, J = 8.0, 4.6
Hz, 1H), 7.76 (br, 1H), 8.10 (d, J = 8.6 Hz, 1H), 8.21 (d, J = 8.0 Hz, 1H), 8.82 (d, J = 4.6 Hz, 1H), 9.10 (s,
1H). Anal. Calcd for C14H9Br2ClN2O: C, 40.37; H, 2.18; N, 6.73. Found: C, 40.39; 2.23; N, 6.77.
N-[2-(2,2-Dibromoethenyl)-4-methoxyphenyl]benzamide (2j): a white solid; mp 127–130 ˚C
(hexane/CH2Cl2); IR 3235, 1640, 1619, 1602 cm–1; 1H NMR (500 MHz, CDCl3) " 3.83 (s, 3H), 6.95–6.98
(m, 2H), 7.47 (s, 1H), 7.52 (t, J = 7.4 Hz, 2H), 7.58 (t, J = 7.4 Hz, 1H), 7.62 (br, 1H), 7.85–7.88 (m, 3H).
Anal. Calcd for C16H13Br2NO2: C, 46.75; H, 3.19; N, 3.41. Found: C, 46.70; 3.39; N, 3.36.
4-Chloro-N-[2-(2,2-dibromoethenyl)-4-methoxyphenyl]benzamide (2k): a pale-yellow solid; mp
156–158 ˚C (hexane/CH2Cl2); IR 3244, 1647 cm–1; 1H NMR (500 MHz, CDCl3) " 3.83 (s, 3H), 6.94–6.97
(m, 2H), 7.45 (s, 1H), 7.49 (d, J = 8.6 Hz, 2H), 7.57 (br, 1H), 7.79–7.83 (m, 3H). Anal. Calcd for
C16H12Br2ClNO2: C, 43.13; H, 2.71; N, 3.14. Found: C, 43.05; 2.76; N, 3.02.
General Procedure for the Preparation of 2-Aryl-(Z)-4-(halomethylidene)-4H-1,3-benzoxazines (3).
To a stirred solution of 2 (1.0 mmol) in DMF (5 mL) at 0 ˚C was added NaH (60% in mineral oil; 47 mg,
1.2 mmol) in several portions. The mixture was stirred at the same temperature (for X = Br) or rt (for X =
Cl), until complete consumption of the starting material (TLC on silica gel; about 5 h for X =Br and

HETEROCYCLES, Vol. 89, No. 12, 2014
2735
overnight for X = Cl). Water (20 mL) was then added and the resulting mixture was extracted with
AcOEt (3 $ 10 mL). The combined extracts were washed with water (3 $ 10 mL) and brine (5 mL), dried
(Na2SO4), and concentrated by evaporation. The residual solid was recrystallized from hexane/CH2Cl2 to
give 3.
(Z)-4-(Bromomethylidene)-2-phenyl-4H-1,3-benzoxazine (3a). a pale-yellow solid; mp 105–107 ˚C; IR
1645, 1612 cm–1; 1H NMR (500 MHz, CDCl3) " 5.98 (s, 1H), 7.23 (td, J = 7.6, 2.3 Hz, 1H), 7.36–7.42 (m,
3H), 7.49 (t, J = 7.6 Hz, 2H), 7.55 (tt, J = 7.6, 1.5 Hz, 1H), 8.28 (d, J = 7.6 Hz, 2H); 13C NMR (125 MHz,
CDCl3) " 79.79, 119.90, 121.72, 126.90, 127.84, 128.02, 128.45, 130.82, 131.04, 132.01, 138.24, 147.68,
154.12. HR-MS (DART, positive). Calcd for C15H11BrNO (M+H): 300.0024. Found: m/z 300.0017. Anal.
Calcd for C15H10BrNO: C, 60.02; H, 3.36; N, 4.67. Found: C, 59.98; H, 3.61; N, 4.63.
(Z)-4-(Bromomethylidene)-2-(3-methylphenyl)-4H-1,3-benzoxazine (3b): a pale-yellow solid; mp
131–133 ˚C ; IR 1644, 1613 cm–1; 1H NMR (600 MHz, CDCl3) " 2.45 (s, 3H), 5.96 (s, 1H), 7.21 (td, J =
7.5, 1.6 Hz, 1H), 7.36–7.40 (m, 5H), 8.08 (d, J = 9.2 Hz, 1H), 8.09 (d, J = 0.8 Hz, 1H); 13C NMR (CDCl3)
" 21.50, 79.76, 119.95, 121.76, 125.27, 126.89, 127.82, 128.42, 128.57, 130.78, 131.08, 132.92, 128.22,
138.35, 147.76, 154.40. HR-MS (DART, positive). Calcd for C16H13BrNO (M+H): 314.0180. Found: m/z
314.0179. Anal. Calcd for C16H12BrNO: C, 61.17; H, 3.85; N, 4.46. Found: C, 61.17; H, 4.01; N, 4.43.
(Z)-4-(Bromomethylidene)-2-(4-chlorophenyl)-4H-1,3-benzoxazine (3c): a pale-yellow solid; mp
179–182 ˚C ; IR 1646, 1613 cm–1; 1H NMR (500 MHz, CDCl3) " 5.97 (s, 1H), 7.23 (dd, J = 8.0, 7.4 Hz,
13
1H), 7.33–7.40 (m, 3H), 7.45 (d, J = 8.0 Hz, 2H), 8.20 (d, J = 8.0 Hz, 2H); C NMR (CDCl3) " 80.06,
119.89, 121.75, 126.94, 128.06, 128.78, 129.35, 131.13 (2 overlapped Cs), 138.05, 138.29, 147.61,
153.24. HR-MS (DART, positive). Calcd for C15H10BrClNO (M+H): 333.9634. Found: m/z 333.9624.
Anal. Calcd for C15H9BrClNO: C, 53.84; H, 2.71; N, 4.19. Found: C, 53.55; 2.85; N, 4.08.
(Z)-4-(Bromomethylidene)-2-(3-methoxyphenyl)-4H-1,3-benzoxazine (3d): a pale-yellow solid; mp
1
113–115 ˚C ; IR 1641, 1615 cm–1; H NMR (500 MHz, CDCl3) " 3.90 (s, 3H), 5.96 (s, 1H), 7.09 (d, J =
8.0 Hz, 1H), 7.22 (dd, J = 8.0, 6.9 Hz, 1H), 7.36–7.41 (m, 4H), 7.82 (s, 1H), 7.88 (d, J = 7.4 Hz, 1H); 13C
NMR (125 MHz, CDCl3) " 55.40, 79.80, 112.47, 118.63, 119.95, 120.58, 121.73, 126.94, 127.89, 129.50,
131.04, 132.18, 138.25, 147.70, 153.97, 159.61. HR-MS (ESI, positive). Calcd for C16H13BrNO2 (M+H):
330.0129. Found: m/z 330.0119. Anal. Calcd for C16H12BrNO2: C, 58.20; H, 3.66; N, 4.24. Found: C,
58.06; 3.86; N, 4.12.
(Z)-4-(Chloromethylidene)-2-phenyl-4H-1,3-benzoxazine (3e): a pale-yellow solid; mp 100–101 ˚C ;
IR 1638, 1612 cm–1; 1H NMR (500 MHz, CDCl3) " 5.98 (s, 1H), 7.22 (td, J = 8.0, 1.7 Hz, 1H), 7.37–7.39
13
(m, 3H), 7.49 (t, J = 7.4 Hz, 2H), 7.55 (dd, J = 7.4, 6.9 Hz, 1H), 8.27 (d, J = 7.4 Hz, 2H); C NMR
(CDCl3) " 92.52, 119.43, 121.12, 126.93, 127.75, 128.00, 128.44, 130.89, 130.93, 131.98, 138.23, 146.22,

2736
HETEROCYCLES, Vol. 89, No. 12, 2014
153.99. HR-MS (ESI, positive). Calcd for C15H11ClNO (M+H): 256.0529. Found: m/z 256.0523. Anal.
Calcd for C15H10ClNO: C, 70.46; H, 3.94; N, 5.48. Found: C, 70.32; 3.91; N, 5.41.
(Z)-4-(Chloromethylidene)-2-(thiophen-2-yl)-4H-1,3-benzoxazine (3f): a pale-yellow solid; mp
114–116 ˚C ; IR 1639, 1611 cm–1; 1H NMR (500 MHz, CDCl3) " 5.94 (s, 1H), 7.14 (dd, J = 5.2, 3.4 Hz,
1H), 7.18 (t, J = 7.4 Hz, 1H), 7.30–7.37 (m, 3H), 7.54 (dd, J = 5.2, 1.1 Hz, 1H), 7.90 (dd, J = 3.4, 1.1 Hz,
1H); 13C NMR (CDCl3) " 92.67, 119.22, 121.20, 126.60, 127.52, 127.91, 130.88, 130.94, 131.16, 134.85,
138.15, 146.07, 150.76. HR-MS (DART, positive). Calcd for C13H9ClNOS (M+H): 262.0093. Found: m/z
262.0086. Anal. Calcd for C13H8ClNOS: C, 59.66; H, 3.08; N, 5.35. Found: C, 59.33; H, 3.26; N, 5.18.
(Z)-4-(Bromomethylidene)-6-chloro-2-phenyl-4H-1,3-benzoxazine (3g): a pale-yellow solid; mp
1
173–175 ˚C ; IR 1641, 1612 cm–1; H NMR (500 MHz, CDCl3) " 5.97 (s, 1H), 7.26 (d, J = 8.6 Hz, 1H),
7.32 (dd, J = 8.6, 2.3 Hz, 1H), 7.35 (d, J = 2.3 Hz, 1H), 7.48 (dd, J = 8.0, 6.9 Hz, 2H), 7.54 (t, J = 8.0 Hz,
1H), 8.24 (d, J = 6.9 Hz, 2H);13C NMR (CDCl3) " 81.16, 121.20, 121.63, 128.07, 128.24, 128.50, 130.50,
131.09, 132.22, 133.19, 136.92, 146.62, 154.34. HR-MS (DART, positive). Calcd for C15H10BrClNO
(M+H): 333.9634. Found: m/z 333.9626. Anal. Calcd for C15H9BrClNO: C, 53.84; H, 2.71; N, 4.19.
Found: C, 53.58; H, 2.81; N, 4.14.
(Z)-4-(Bromomethylidene)-6-chloro-2-(3-chlorophenyl)-4H-1,3-benzoxazine (3h): a pale-yellow
solid; mp 152–154 ˚C ; IR 1642, 1611 cm–1; 1H NMR (500 MHz, CDCl3) " 5.98 (s, 1H), 7.27 (d, J = 8.6
Hz, 1H), 7.32–7.34 (m, 2H), 7.41 (dd, J = 8.0, 7.4 Hz, 1H), 7.50 (dt, J = 8.0, 1.1 Hz, 1H), 8.10 (dt, J = 8.0,
1.1 Hz, 1H), 8.20 (t, J = 1.1 Hz, 1H); 13C NMR (CDCl3) " 81.59, 121.23, 121.66, 126.09, 128.05, 128.34,
129.77, 131.18, 132.17, 132.27, 133.64, 134.65, 136.51, 146.41, 153.03. HR-MS (DART, positive).
Calcd for C15H9BrCl2NO (M+H): 367.9244. Found: m/z 367.9239. Anal. Calcd for C15H8BrCl2NO: C,
48.82; H, 2.18; N, 3.80. Found: C, 48.60; H, 2.35; N, 3.53.
(Z)-4-(Bromomethylidene)-6-chloro-2-(pyridin-3-yl)-4H-1,3-benzoxazine (3i): a pale-yellow solid; mp
190–192 ˚C ; IR (KBr) 1645, 1616 cm–1; 1H NMR (500 MHz, CDCl3) " 6.04 (s, 1H), 7.33 (d, J = 8.0 Hz,
1H), 7.37 (dd, J = 8.0, 2.3 Hz, 1H), 7.40 (d, J = 2.3 Hz, 1H), 7.44 (dd, J = 8.0, 5.2 Hz, 1H), 8.49 (dt, J =
8.0, 1.7 Hz, 1H), 8.78 (dd, J = 5.2, 1.7 Hz, 1H), 9.47 (d, J = 1.7 Hz, 1H); 13C NMR (125 MHz, CDCl3) "
81.90, 121.31, 121.72, 123.26, 126.56, 128.40, 131.23, 133.84, 135.23, 136.30, 146.25, 149.48, 152.58
(two overlapped Cs). HR-MS (DART, positive) Calcd for C14H9BrClN2O (M+H): 334.9587. Found: m/z
334.9580. Anal. Calcd for C14H8BrClN2O: C, 50.11; H, 2.40; N, 8.35. Found: C, 49.88; H, 2.41; N, 8.30.
(Z)-4-(Bromomethylidene)-6-methoxy-2-phenyl-4H-1,3-benzoxazine (3j): a yellow solid; mp 141–144
1
˚C ; IR 1645, 1611 cm–1; H NMR (500 MHz, CDCl3) " 3.82 (s, 3H), 5.93 (s, 1H), 6.85 (d, J = 2.3 Hz,
1H), 6.95 (dd, J = 8.6, 2.3 Hz, 1H), 7.32 (8.6 Hz, 1H), 7.46–7.53 (m, 3H), 8.24 (dd, J = 6.9, 1.7 Hz, 2H);
13C NMR (CDCl3) " 55.59, 79.70, 105.78, 117.44, 120.60, 127.37, 127.72, 128.30, 128.41, 131.60,
132.06, 147.71, 152.24, 159.02. HR-MS (DART, positive). Calcd for C16H13BrNO2 (M+H): 330.0129.

HETEROCYCLES, Vol. 89, No. 12, 2014
2737
Found: m/z 330.0121. Anal. Calcd for C16H12BrNO2: C, 58.20; H, 3.66; N, 4.24. Found: C, 58.03; H, 3.74;
N, 4.18.
(Z)-4-(Bromomethylidene)-2-(4-chlorophenyl)-6-methoxy-4H-1,3-benzoxazine (3k): a pale-yellow
1
solid; mp 168–171 ˚C ; IR 1648, 1616 cm–1; H NMR (500 MHz, CDCl3) " 3.82 (s, 3H), 5.92 (s, 1H),
6.83 (d, J = 2.9 Hz, 1H), 6.94 (dd, J = 8.6, 2.9 Hz, 1H), 7.29 (d, J = 8.6 Hz, 1H), 7.43 (d, J = 8.6 Hz, 2H),
13
8.16 (d, J = 8.6 Hz, 2H); C NMR (CDCl3) " 55.60, 79.96, 105.83, 117.47, 120.56, 128.33, 128.71,
129.00, 129.52, 131.81, 137.82, 147.56, 151.46, 159.16. HR-MS (ESI, positive). Calcd for
C16H12BrClNO2 (M+H): 363.9740. Found: m/z 363.9737. Anal. Calcd for C16H11BrClNO2: C, 52.70; H,
3.04; N, 3.84. Found: C, 52.42; H, 3.09; N, 3.80.
Typical Procedure for the Preparation of Compounds (7). (Z)-2-Chloro-1-phenyl-2-(2-phenyl-4H-
3,1-benzxazin-4-ylidene)ethanol (7a). To a stirred solution of 3e (0.12 g, 0.46 mmol) in THF (3 mL) at
–78 ˚C was added n-BuLi (1.6 M in hexane; 0.46 mmol) dropwise. After 10 min, PhCHO (49 mg, 0.46
mmol) was added and stirring was continued for an additional 15 min. Saturated aqueous NH4Cl (10 mL)
was added and temperature was raised to rt. The mixture was extracted with AcOEt (3 $ 10 mL) and the
combined extracts were washed with brine (10 mL), dried (Na2SO4), and concentrated by evaporation.
The residual solid was purified by recrystallization to afford 7a (0.11 g, 68%); a lemon-yellow solid; mp
1
204–206 ˚C (hexane/THF); IR 3224, 1640, 1611 cm–1; H NMR (500 MHz, DMSO-d6) " 6.06 (s, 1H),
6.32 (s, 1H), 7.27 (t, J = 7.4 Hz, 1H), 7.36 (t, J = 7.4 Hz, 2H), 7.40–7.46 (m, 4H), 7.56–7.59 (m, 3H),
7.64 (t, J = 7.4 Hz, 1H), 7.72 (d, J = 7.4 Hz, 1H), 8.20 (d, J = 7.4 Hz, 2H); 13C NMR (DMSO-d6) " 69.54,
118.55, 119.44, 125.70, 125.86, 126.12, 127.33, 127.76, 127.92, 128.12, 128.91, 129.94, 131.64, 132.65,
140.31, 141.15, 142.00, 154.71. HR-MS (ESI, positive). Calcd for C22H17ClNO2 (M+H): 362.0948.
Found: m/z 362.0944. Anal. Calcd for C22H16ClNO2: C, 73.03; H, 4.46; N, 3.87. Found: C, 72.82; H, 4.35;
N, 3.80.
Methyl
(Z)-3-Chloro-2-hydroxy-2-methyl-3-(2-phenyl-4H-3,1-benzoxazin-4-ylidene)propanoate
1
(7b): a yellow solid; mp 148–150 ˚C (hexane/CH2Cl2); IR 3280, 1749, 1633 cm–1; H NMR (500 MHz,
CDCl3) " 1.83 (s, 3H), 3.37 (s, 3H), 3.59 (s, 1H), 7.26 (dd, J = 8.0, 7.4 Hz, 1H), 7.39 (dd, J = 8.0, 1.1 Hz,
1H), 7.45 (td, J = 7.4, 1.1 Hz, 1H), 7.50 (dd, J = 8.6, 7.4 Hz, 2H), 7.55 (tt, J = 7.4, 1.7 Hz, 1H), 7.80 (dd,
13
J = 7.4, 1.7 Hz, 1H), 8.32 (dd, J = 8.6, 1.7 Hz, 2H); C NMR (CDCl3) " 28.63, 53.07, 76.40, 114.66,
119.85, 125.02, 126.63, 127.44, 128.44, 128.49, 130.62, 131.52, 132.16, 140.91, 145.29, 155.78, 174.92.
HR-MS (ESI, positive). Calcd for C19H17ClNO4 (M+H): 358.0846. Found: m/z 358.0838. Anal. Calcd for
C19H16ClNO4: C, 63.78; H, 4.51; N, 3.91. Found: C, 63.73; H, 4.63; N, 3.89.
ACKNOWLEDGEMENTS

2738
HETEROCYCLES, Vol. 89, No. 12, 2014
We would like to thank Mrs. Miyuki Tanmatsu of our university for recording mass spectra and
performing combustion analyses.
REFERENCES AND NOTES
1. Transition metal-catalyzed or electrophile-mediated cyclization of N-(2-alkynylphenyl)carboxylic
amides: (a) M. Costa, N. D. Cà, B. Gabriele, C. Massera, G. Salerno, and M. Soliani, J. Org. Chem.,
2004, 69, 2469; (b) T. Saito, S. Ogawa, N. Takei, N. Katsumura, and T. Otani, Org. Lett., 2011, 13,
1098; (c) W.-C. Lee, H.-C. Shen, W.-P. Hu, W.-S. Lo, C. Murali, J. K. Vandavasi, and J.-J. Wang,
Adv. Synth. Catal., 2013, 354, 2218; (d) J. K. Vandavasi, K.-K. Kuo, W.-P. Hu, H.-C. Shen, W.-S.
Lo, and J.-J. Wang, Org. Biomol. Chem., 2013, 11, 6520; (e) A. Sinai, A. Mészáros, T. Gáti, V.
Kudar, A. Pállo, and Z. Novák, Org. Lett., 2013, 15, 5654; (f) A. L. Stein, F. N. Bilhert, D. F. Back,
and G. Zeni, Adv. Synth. Catal., 2014, 356, 501.
2. Electrophile-mediated cyclization of 2-isocyanophenyl ketones under non-metallic conditions: (a) K.
Kobayashi, Y. Okamura, and H. Konishi, Synthesis, 2009, 1494; (b) K. Kobayashi, Y. Okamura, S.
Fukamachi, and H. Konishi, Heterocycles, 2010, 81, 1253.
3. K. Kobayashi, K. Yamane, I. Nozawa, and K. Ezaki, Helv. Chim. Acta, 2014, 97, 315.
4. H.-F. He, S. Dong, Y. Chen, Y. Yang, Y. Le, and W. Bao, Tetrahedron, 2012, 68, 3112.
5. Y. Q. Fang and M. Lautens, J. Org. Chem., 2008, 73, 538.
6. T. O. Vieira, L. A. Meaney, Y.-L. Shi, and H. Alper, Org. Lett., 2008, 10, 4899.
7. A. R. Kunzer and M. D.Wendt, Tetrahedron Lett., 2011, 52, 1815.
8. B. Jiang, K. Tao, W. Shen, and J. Zhang, Tetrahedron Lett., 2010, 51, 6342.